https://chinahealthreport.com/article/907118948-victoria-basil-shines-in-nyc-receiving-recognition-through-the-independent-press-award-and-in-nyc-s-times-square China Health Report en PressRelease 2026-04-22T14:45:00+00:00 Victoria Basil Shines in NYC, Receiving Recognition Through the INDEPENDENT PRESS AWARD® and in NYC's Times Square https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837180-author-victoria-basil-830x1214.png https://chinahealthreport.com/article/907335058-agora-and-thymia-partner-to-enable-real-time-health-and-safety-intelligence-across-voice-communications China Health Report en PressRelease 2026-04-22T13:00:00+00:00 Agora and thymia Partner to Enable Real-Time Health and Safety Intelligence Across Voice Communications https://ml.globenewswire.com/media/5d0b71db-c424-433c-b190-ec8bf61ca1ca/small/agora-logo-rgb-blue-png.png https://chinahealthreport.com/article/906304051-new-genetic-insights-into-developmental-dysplasia-of-the-hip China Health Report en PressRelease 2026-04-21T10:30:00+00:00 New Genetic Insights into Developmental Dysplasia of the Hip https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835154-infant-wearing-harness-to-corre-602x451.jpeg https://chinahealthreport.com/article/907145205-leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-enters-phase-trial-with-first-patient-dosing-in-gastric-cancer-pioneering China Health Report en PressRelease 2026-04-21T13:47:09+00:00 Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies https://ml.globenewswire.com/media/MGZhMTI3YWEtMDgwZS00ZGVlLTg5MzItYjQxOWI5ODY4Mjc3LTEzMDgzODktMjAyNi0wNC0yMS1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://chinahealthreport.com/article/907117969-preclinical-data-of-novel-b7-h3-adc-icp-b794-unveiled-at-2026-aacr-demonstrating-superior-anti-tumor-activity-and-safety China Health Report en PressRelease 2026-04-21T10:00:00+00:00 Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://chinahealthreport.com/article/907007986-junshi-biosciences-presents-results-from-js207-pd-1-vegf-bsab-phase-2-combo-studies-and-js212-egfr-her3-adc-fih-phase-1-2-study-at-aacr-2026 China Health Report en PressRelease 2026-04-20T21:00:00+00:00 Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026 https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png